Ping An Biomedical plans to buy three tumor-related patents for $2 million-$2.5 million
PASW•Ping An Biomedical signed a letter of intent to acquire three tumor-related patents from Future Biotechnology Group for $2 million to $2.5 million, subject to due diligence and a definitive agreement; the acquisition alone is not expected to generate material near-term revenue.
1. Proposed patent acquisition
Ping An Biomedical signed a letter of intent to acquire three tumor-related medical technology patents from Future Biotechnology Group for $2 million to $2.5 million. The proposed acquisition remains subject to due diligence and a definitive agreement, and alone is not expected to generate material revenue in the near term.
